Recombinant Fusion Proteins < Recombinant Proteins < Recovery of Function

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Recombinant Proteins

Number of relevant bibliographic references: 10.

Ident.	Authors (with country if any)	Title
001175 (2018)	Yusuke Takayama [Japon] ; Tetsuya Kubota [Japon] ; Yoshitaka Ogino [Japon] ; Hiroshi Ohnishi [Japon] ; Kazuto Togitani [Japon] ; Akihito Yokoyama [Japon]	TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.
001291 (2018)	Chuanfei Yu [République populaire de Chine] ; Junxia Cao [République populaire de Chine] ; Lan Wang [République populaire de Chine] ; Yalan Yang [République populaire de Chine] ; Yongbo Ni [République populaire de Chine] ; Junzhi Wang [République populaire de Chine]	Measuring the bioactivity of anti-IL-6/anti-IL-6R therapeutic antibodies: presentation of a robust reporter gene assay.
002139 (2015)	E M Dijkgraaf [Pays-Bas] ; S J A M. Santegoets [Pays-Bas] ; A K L. Reyners ; R. Goedemans [Pays-Bas] ; M C A. Wouters [Pays-Bas] ; G G Kenter [Pays-Bas] ; A R Van Erkel ; M I E. Van Poelgeest [Pays-Bas] ; H W Nijman ; J J M. Van Der Hoeven [Pays-Bas] ; M J P. Welters [Pays-Bas] ; S H Van Der Burg [Pays-Bas] ; J R Kroep [Pays-Bas]	A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.
003392 (2013)	Peter N. Morcos [États-Unis] ; XIAOPING ZHANG [États-Unis] ; Christine Mcintyre [Royaume-Uni] ; Beate Bittner [Suisse] ; Lucy Rowell [Royaume-Uni] ; Zubair Hussain [Royaume-Uni]	Pharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20
003685 (2012)	M. Gallego-Galisteo ; A. Villa-Rubio ; E. Alegre-Del Rey [Espagne] ; E. Márquez-Fernández ; J. J. Ramos-Báez	Indirect comparison of biological treatments in refractory rheumatoid arthritis
004067 (2008)	Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto	The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis.
004096 (2008)	M. Hashizume [Japon] ; N. Hayakawa [Japon] ; M. Mihara [Japon]	IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17
004115 (2008)	Misato Hashizume [Japon] ; Masahiko Mihara [Japon]	Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling
004166 (2007)	Yoshiyuki Ohsugi [Japon]	Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases.
004246 (2005)	Yoshiyuki Ohsugi [Japon] ; Nobuyuki Tsuchimoto	[Pharmacological and clinical profile of anti-human IL-6 receptor antibody (tocilizumab, ACTEMRA), a novel therapeutic drug for Castleman's disease].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Recombinant Proteins" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Recombinant Proteins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Recombinant Proteins
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021